Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,575 | 357 | 556 | 0 | 0 |
| Other current assets | 0 | 597 | 597 | 0 | 0 |
| TOTAL | $7,737 | $1,012 | $1,339 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 282 | 315 | 355 | N/A | N/A |
| TOTAL | $282 | $315 | $355 | $N/A | $N/A |
| Total Assets | $8,019 | $1,327 | $1,694 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 277 | 747 | 387 | 0 | 0 |
| Accrued Expenses | 610 | 537 | 544 | 0 | 0 |
| TOTAL | $1,366 | $2,099 | $1,776 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 468 | 797 | 816 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 1,000 | 500 | 0 | 0 |
| TOTAL | $5 | $1,005 | $505 | $N/A | $N/A |
| Total Liabilities | $1,371 | $3,104 | $2,281 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 157,500 | 142,290 | N/A | N/A | N/A |
| Common Shares | 16 | 10 | 10 | 0 | 0 |
| Retained earnings | -13,801 | -6,203 | -4,277 | 0 | 0 |
| Other shareholders' equity | 9,424 | 0 | 0 | 0 | 0 |
| TOTAL | $6,648 | $-1,777 | $-587 | $0 | $0 |
| Total Liabilities And Equity | $8,019 | $1,327 | $1,694 | $0 | $0 |